| -0.20 / -0.81%|
The 9 analysts offering 12-month price forecasts for PharMerica Corp have a median target of 33.00, with a high estimate of 34.00 and a low estimate of 24.00. The median estimate represents a +34.20% increase from the last price of 24.59.
The current consensus among 9 polled investment analysts is to Buy stock in PharMerica Corp. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.